Generation of a TPH2-EGFP reporter cell line for purification and monitoring of human serotonin neurons in vitro and in vivo

Stem Cell Reports. 2022 Oct 11;17(10):2365-2379. doi: 10.1016/j.stemcr.2022.08.012. Epub 2022 Sep 22.

Abstract

Generation of serotonin neurons (SNs) from human pluripotent stem cells (hPSCs) provides a promising platform to explore the mechanisms of serotonin-associated neuropsychiatric disorders. However, neural differentiation always yields heterogeneous cell populations, making it difficult to identify and purify SNs in vitro or track them in vivo following transplantation. Herein, we generated a TPH2-EGFP reporter hPSC line with insertion of EGFP into the endogenous tryptophan hydroxylase 2 (TPH2) locus using CRISPR-Cas9-mediated gene editing technology. This TPH2-reporter, which faithfully indicated TPH2 expression during differentiation, enabled us to obtain purified SNs for subsequent transcriptional analysis and study of pharmacological responses to antidepressants. In addition, the reporter system showed strong EGFP expression to indicate SNs, which enabled us to explore in vitro and ex vivo electrophysiological properties of SNs. In conclusion, this TPH2-EGFP reporter cell line might be of great significance for studies on human SN-related development and differentiation, drug screening, disease modeling, and cell replacement therapies.

Keywords: CRISPR-Cas9; TPH2 reporter; differentiation; electrophysiology; human pluripotent stem cells; serotonin neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / genetics
  • Cell Line
  • Genes, Reporter
  • Humans
  • Neurons / metabolism
  • Pluripotent Stem Cells* / metabolism
  • Serotonin*
  • Tryptophan Hydroxylase / genetics
  • Tryptophan Hydroxylase / metabolism

Substances

  • Serotonin
  • TPH2 protein, human
  • Tryptophan Hydroxylase